Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Jul 25, 2024 | 11.29 | +0.36 |
Oak Valley Bancorp | OVLY | Jul 25, 2024 | 26.89 | -0.81 |
Oak Woods Acquisition | OAKU | Jul 25, 2024 | 10.93 | 0.00 |
Oaktree Capital A Pref | OAK-A | Jul 25, 2024 | 22.38 | -0.53 |
Oaktree Capital Group B Pref | OAK-B | Jul 25, 2024 | 22.16 | -0.40 |
Oaktree Specialty | OCSL | Jul 25, 2024 | 18.11 | +1.17 |
Oatly ADR | OTLY | Jul 25, 2024 | 0.95 | -1.56 |
Oblong | OBLG | Jul 25, 2024 | 0.16 | +2.56 |
OCA Acquisition A | OCAX | Jul 25, 2024 | 11.20 | 0.00 |
Occidental Petroleum | OXY | Jul 25, 2024 | 60.53 | +0.77 |
Ocean Biomedical | OCEA | Jul 25, 2024 | 1.12 | -2.61 |
Ocean Power Technologies | OPTT | Jul 25, 2024 | 0.41 | +18.88 |
Oceaneering International | OII | Jul 25, 2024 | 28.95 | +13.75 |
OceanFirst Financial | OCFC | Jul 25, 2024 | 18.37 | +3.38 |
OceanFirst Pref | OCFCP | Jul 25, 2024 | 25.03 | +0.12 |
OceanPal | OP | Jul 25, 2024 | 1.83 | -4.19 |
Ocugen | OCGN | Jul 25, 2024 | 1.63 | +1.88 |
Ocular Therapeutix | OCUL | Jul 25, 2024 | 8.28 | +4.68 |
Oculis | OCS | Jul 25, 2024 | 11.45 | -0.61 |
Ocuphire Pharma | OCUP | Jul 25, 2024 | 2.04 | +2.51 |
Ocwen Financial | OCN | Jul 25, 2024 | 25.08 | 0.00 |
Oddity Tech | ODD | Jul 25, 2024 | 41.16 | +5.27 |
Odyssey Marine Exploration | OMEX | Jul 25, 2024 | 4.45 | -4.71 |
Offerpad Solutions A | OPAD | Jul 25, 2024 | 4.60 | +2.91 |
Office Properties | OPI | Jul 25, 2024 | 2.58 | +1.57 |
OFG Bancorp | OFG | Jul 25, 2024 | 46.14 | +1.67 |
OFS Capital | OFS | Jul 25, 2024 | 8.54 | -0.12 |
OFS Credit | OCCI | Jul 25, 2024 | 7.14 | -0.11 |
OFS Credit C Pref | OCCIO | Jul 25, 2024 | 24.15 | -0.45 |
OFS Credit E Pref | OCCIN | Jul 25, 2024 | 23.15 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.